120 related articles for article (PubMed ID: 8280369)
61. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
62. Gastrin releasing peptide in human neuroendocrine tumours.
Bostwick DG; Bensch KG
J Pathol; 1985 Dec; 147(4):237-44. PubMed ID: 3003308
[TBL] [Abstract][Full Text] [Related]
63. Gastrin releasing peptide (GRP) binding sites in human bronchi.
Baraniuk JN; Lundgren JD; Shelhamer JH; Kaliner MA
Neuropeptides; 1992 Feb; 21(2):81-4. PubMed ID: 1557184
[TBL] [Abstract][Full Text] [Related]
64. Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.
Weber S; Zuckerman JE; Bostwick DG; Bensch KG; Sikic BI; Raffin TA
J Clin Invest; 1985 Jan; 75(1):306-9. PubMed ID: 2981251
[TBL] [Abstract][Full Text] [Related]
65. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
[TBL] [Abstract][Full Text] [Related]
66. Gastrin-releasing peptide: binding and functional studies in mouse pancreatic islets.
Wahl MA; Landsbeck EA; Ammon HP; Verspohl EJ
Pancreas; 1992; 7(3):345-51. PubMed ID: 1594556
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
Kahán Z; Sun B; Schally AV; Arencibia JM; Cai RZ; Groot K; Halmos G
Cancer; 2000 Mar; 88(6):1384-92. PubMed ID: 10717621
[TBL] [Abstract][Full Text] [Related]
68. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
69. Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide.
Moody TW; Mahmoud S; Staley J; Naldini L; Cirillo D; South V; Felder S; Kris R
J Mol Neurosci; 1989; 1(4):235-42. PubMed ID: 2561955
[TBL] [Abstract][Full Text] [Related]
70. Mitogenic action of gastrin-releasing polypeptide on isolated epiphyseal growth plate chondrocytes from the ovine fetus.
Hill DJ; McDonald TJ
Endocrinology; 1992 May; 130(5):2811-9. PubMed ID: 1572294
[TBL] [Abstract][Full Text] [Related]
71. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
Ohlsson B; Fredäng N; Axelson J
Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
[TBL] [Abstract][Full Text] [Related]
72. Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer.
Halmos G; Pinski J; Szoke B; Schally AV
Cancer Lett; 1994 Sep; 85(1):111-8. PubMed ID: 7923093
[TBL] [Abstract][Full Text] [Related]
73. Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancer.
Vangsted AJ; Andersen EV; Nedergaard L; Zeuthen J
Breast Cancer Res Treat; 1991 Oct; 19(2):119-28. PubMed ID: 1661625
[TBL] [Abstract][Full Text] [Related]
74. Paracrine effects of bombesin/gastrin-releasing peptide and other growth factors on pulmonary neuroendocrine cells in vitro.
Speirs V; Bienkowski E; Wong V; Cutz E
Anat Rec; 1993 May; 236(1):53-61; discussion 62-7. PubMed ID: 8389533
[TBL] [Abstract][Full Text] [Related]
75. Biotinylation of a bombesin/gastrin-releasing peptide analogue for use as a receptor probe.
Anton PA; Reeve JR; Rivier JE; Vidrich A; Schepp W; Shanahan F
Peptides; 1991; 12(2):375-81. PubMed ID: 1648717
[TBL] [Abstract][Full Text] [Related]
76. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
77. High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa.
Preston SR; Woodhouse LF; Jones-Blackett S; Miller GV; Primrose JN
Br J Cancer; 1995 May; 71(5):1087-9. PubMed ID: 7734305
[TBL] [Abstract][Full Text] [Related]
78. Evidence for the direct action of gastrin-releasing peptide (GRP) on amylase secretion from rat pancreatic acini: an assessment using a perifusion system.
Shinozaki H; Funakoshi A
Jpn J Physiol; 1988; 38(3):299-307. PubMed ID: 2460654
[TBL] [Abstract][Full Text] [Related]
79. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
80. Identification of functional GRP-preferring bombesin receptors on human melanoma cells.
Pansky A; Peng F; Eberhard M; Baselgia L; Siegrist W; Baumann JB; Eberle AN; Beglinger C; Hildebrand P
Eur J Clin Invest; 1997 Jan; 27(1):69-76. PubMed ID: 9041380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
